Search

Karty

Karty

diacerein

Manufacturer:

CCL Pharma

Distributor:

Manawhari
Concise Prescribing Info
Contents
Diacerein
Indications/Uses
OA of the hip or knee.
Click to view Karty detailed prescribing information
Dosage/Direction for Use
Initially 1 cap at night time for 2-4 wk; gradually adjust dose to 2 cap bd.
Click to view Karty detailed prescribing information
Overdosage
View Karty overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food: Best taken w/ food to increase absorption.
Contraindications
Hypersensitivity.
Click to view Karty detailed prescribing information
Special Precautions
Monitor lab parameters including hepatic enzymes every 6 mth in long-term therapy. Severe renal impairment. Hepatic impairment. Not recommended in women attempting to conceive, lactating women & ped population. Elderly.
Click to view Karty detailed prescribing information
Adverse Reactions
Accelerated intestinal transit time (diarrhea); abdominal pain.
Click to view Karty detailed prescribing information
Drug Interactions
Use w/ laxatives is contraindicated.
Click to view Karty detailed prescribing information
Storage
View Karty storage conditions for details to ensure optimal shelf-life.
Description
View Karty description for details of the chemical structure and excipients (inactive components).
Action
View Karty mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Other Drugs Acting on Musculo-Skeletal System
ATC Classification
M01AX21 - diacerein ; Belongs to the class of other non-steroidal antiinflammatory and antirheumatic products.
Presentation/Packing
Form
Karty cap 50 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in